On October 7, we launched a three-part series to showcase how the distribution industry is making a difference in local communities across the country. In part one, we explored how HDA’s distributor members are leaving their imprint upon communities through corporate, foundation and employee support.
Long before the COVID-19 pandemic, HDA healthcare distributors recognized the vital role that philanthropy plays in building healthier communities — and the industry’s responsibility in leading these efforts.
Since the Drug Supply Chain Security Act (DSCSA) was enacted nearly 10 years ago, healthcare supply chain stakeholders have made steady progress in meeting regularly (through HDA and other settings) to discuss compliance strategies, establish recommended guidelines and build consensus on key milestones.
With the Delta variant surging across the United States, the fight against COVID-19 — and in turn, the most extensive vaccination campaign in our country’s history — is far from over. As the effects of the virus continue to reverberate, the Biden administration recently authorized booster shots, and the Food and Drug Administration granted full approval of the first COVID-19 vaccine in an effort to increase vaccination rates across the U.S.
Earlier this month, HDA published two new resources for supply chain stakeholders to ensure the proper handling of new products moving through the supply chain and removal of products that are recalled or need to be withdrawn.